Merck Manual

Please confirm that you are not located inside the Russian Federation

honeypot link

Cutaneous T-cell Lymphomas

(Mycosis Fungoides; Sézary Syndrome)

By

Peter Martin

, MD, Weill Cornell Medicine;


John P. Leonard

, MD, Weill Cornell Medicine

Last full review/revision Jul 2020| Content last modified Jul 2020
Click here for the Professional Version
Topic Resources

The most common types of CTCL are

  • Mycosis fungoides

  • Sézary syndrome

Most people who develop CTCL are older than 50. It originates from mature T cells (T lymphocytes) and first affects the skin.

Mycosis fungoides starts so subtly and grows so slowly that it may not be noticed initially. It causes a long-lasting, itchy rash—sometimes a small area of thickened, itchy skin that later develops nodules and slowly spreads. In some people, it develops into a form of leukemia (Sézary syndrome). In other people, it progresses to the lymph nodes and internal organs. Even with a biopsy, doctors have trouble diagnosing this disease in its early stages. However, later in the course of the disease, a biopsy shows lymphoma cells in the skin.

Sézary syndrome also starts subtly and grows slowly. It causes the skin to become red all over the body with cracking of the palms and soles. Lymph node enlargement is usually mild. In addition to the rash, people may also have symptoms of fever, night sweats, and weight loss. As with mycosis fungoides, doctors have trouble diagnosing this disease in its early stage even with a skin biopsy. A blood smear (where a drop of blood is examined under a microscope) may show Sézary cells (malignant T cells with a characteristic appearance) and this can help make the diagnosis in addition to a skin biopsy.

Treatment of CTCL can be divided into

  • Therapy directed at the skin, such as light therapy (phototherapy) or topical drugs

  • Bodywide therapy, such as chemotherapy or targeted drugs, usually given intravenously

More Information

The following is an English-language resource that may be useful. Please note THE MANUAL is not responsible for the content of this resource.

NOTE: This is the Consumer Version. DOCTORS: Click here for the Professional Version
Click here for the Professional Version
Others also read
Test your knowledge
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a life-threatening disorder in which certain blood cells become cancerous and rapidly replace normal cells in the bone marrow. As normal blood cells are replaced by cancerous cells, people with AML become anemic from too few red blood cells. They develop infections easily because there are too few white blood cells to fight infections, and their blood does not clot well because of too few platelets. Which of the following additional symptoms of AML may be caused by having too few white blood cells?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

Also of Interest

Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
TOP